ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96,383 | -22.0% | 15,931 | 0.0% | 0.00% | – |
| Q2 2023 | $123,625 | +93.2% | 15,931 | +33.3% | 0.00% | – |
| Q1 2022 | $64,000 | -93.5% | 11,955 | -82.2% | 0.00% | -100.0% |
| Q4 2021 | $987,000 | -74.3% | 67,193 | -63.4% | 0.00% | -75.0% |
| Q3 2021 | $3,837,000 | +41.7% | 183,512 | +19.9% | 0.01% | +60.0% |
| Q2 2021 | $2,708,000 | +10.0% | 153,051 | +52.3% | 0.01% | 0.0% |
| Q1 2021 | $2,462,000 | -25.2% | 100,481 | +3.4% | 0.01% | -28.6% |
| Q4 2020 | $3,290,000 | – | 97,194 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |